DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Schulman CC, De Sy W, Vandendris M. et al.
Belgian multicenter clinical study of alfuzosin, a selective alpha 1-blocker, in the treatment of benign prostatic hyperplasia. The Alfuzosin Belgian Group.
Acta Urol Belg 1994;
62: 15-21
Access:
We do not assume any responsibility for the contents of the web pages of other providers.